New Arrival: EMERSON 5X00106G02 Analog Input Module

Cynosure Tech Automation proudly introduces the EMERSON 5X00106G02 – the precision solution for critical process monitoring in industrial automation systems. This high-performance module sets new standards in signal accuracy for DeltaV DCS environments.

Technical Specifications

  • Model: 5X00106G02
  • Type: 16-Channel Analog Input Module
  • Signal Range: 4-20mA / 0-10V DC with HART protocol support
  • Accuracy: ±0.05% of span at 25°C
  • Isolation: 1500V channel-to-channel and channel-to-ground
  • Update Rate: 50ms per channel
  • Operating Temp: -40°C to +70°C
  • Certifications: ATEX, IECEx, SIL 2 compliant

Industrial Applications

This module excels in demanding process control scenarios:

  • Safety Instrumented Systems: Critical pressure/temperature monitoring in SIS configurations
  • Turbine Control: Vibration and temperature sensing in Bentley Nevada monitoring systems
  • Process Optimization: Real-time data acquisition for DCS-controlled chemical reactors

Real-World Implementation: Petrochemical Plant

At a SINOPEC refinery, 28 units of 5X00106G02 modules monitor 450+ temperature points across distillation columns. They maintain ±0.1% accuracy despite electrical noise from variable frequency drives, preventing costly shutdowns through predictive maintenance alerts.

Why Partner With Cynosure Tech?

  • Asia’s Largest Stock: Immediate access to discontinued and hard-to-find Emerson components
  • Emerson-Certified Engineers: Pre-sales configuration support and post-installation optimization
  • 1-Year Performance Warranty: Comprehensive coverage including calibration verification
  • Obsolete Part Solutions: Specialized sourcing for legacy DeltaV systems

Limited inventory available! Contact our DeltaV specialists:

Chat on WhatsApp

Email: abbdcs36@gmail.com

As Emerson’s authorized partner since 2008, Cynosure Tech Automation guarantees genuine components with full documentation. Serving 600+ facilities across oil & gas, power generation, and pharmaceutical sectors.